Tharimmune Inc (THAR): News,new use for already approved drug,n...

Next 10 Prev Next

Send PM Follow Ignore

Followers	109
Posts	8745
Boards Moderated	2
Alias Born	01/14/2015

81vette

Re: None

Monday, 03/31/2025 1:21:48 PM

Monday, March 31, 2025 1:21:48 PM

News,new use for already approved drug,no trials needed,we have seen some of these run well in past.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent THAR News

Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:45:45 PM
Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy • PR Newswire (US) • 02/17/2026 12:10:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 10:20:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 01:20:38 PM
Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer • PR Newswire (US) • 02/06/2026 01:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 01:20:40 PM
Tharimmune Elects Jill Sommers and William Wiley to Board of Directors • PR Newswire (US) • 02/02/2026 01:15:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/27/2026 02:51:15 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2026 01:50:23 PM
Tharimmune Announces Expanded Role as Super Validator on Canton Network • PR Newswire (US) • 01/26/2026 01:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:12:00 PM
Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering • PR Newswire (US) • 01/22/2026 09:12:00 PM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/21/2026 05:30:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 03:52:16 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/20/2026 02:05:22 PM
Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering • PR Newswire (US) • 01/20/2026 01:45:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/16/2026 09:05:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 09:10:53 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/09/2026 09:34:29 PM
Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 01/06/2026 09:37:15 PM
Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network • PR Newswire (US) • 12/18/2025 01:15:00 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/18/2025 02:28:37 AM

More THAR News

InvestorsHub NewsWire

Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM

DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM

Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM

C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM

RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM

BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent THAR News

More THAR News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent THAR News

Go Ad-Free